from june , 1982 to december , 1984 , 35 consecutive patients with histologically proven non-small cell lung cancer ( nsclc ) were treated either with methotrexate , adriamycin , cyclophosphamide and ccnu ( macc regimen ) or cis-platinum and etoposide ( ddp-vp16 ) .
C0010583
cyclophosphamide
C0065473
macc